
Sign up to save your podcasts
Or


Telehealth Industry Trends and Challenges with Ash SharmaIn this episode of The Investors Corner Podcast by Cedar Grove Capital Management, Chief Investment Officer Paul Cerro welcomes Ash Sharma, writer and founder of the GLP One Digest.
They discuss the evolution and future of telehealth, touching on topics such as consumer health behaviors, limitations and dark sides of telehealth services, and the business model of labs and diagnostics. They delve into the controversial practices within the industry, such as compounded treatments and ethical concerns. The conversation also covers international expansion of telehealth services, particularly in the UK market, and the challenges HIMS is facing with new product offerings.
Finally, they explore the importance of proactive versus reactive healthcare and the impact of tech advancements such as wearables in promoting healthy lifestyles.00:00 Introduction and Guest Introduction03:40 Telehealth Evolution and Market Impact06:49 Limitations and Challenges of Telehealth14:10 The Dark Side of Telehealth23:02 Preventative vs. Reactive Healthcare30:36 HIMSS and Lab Biomarkers Discussion35:18 The Cost of Medical Devices36:03 Compounding Treatments and Business Strategies37:34 Diagnostic Blood Tests and Health Anxiety39:27 The Business of Biomarkers and Medications41:35 Cancer Diagnostics and False Positives45:53 New Product Releases: TRT, HRT, and Peptides54:33 International Expansion and Market Challenges59:46 Telehealth Industry Insights and HIMSS Future01:03:25 Concluding Thoughts and RecommendationsCedar Grove Capital Management Fund: www.cedargrovecapitalmanagement.com
Cedar Grove Capital Management Research: www.cedargroveresearch.comPaul Cerro Twitter: https://x.com/paulcerro
Fund Twitter: https://x.com/cedargrovecm
Ash Twitter: https://x.com/Ashwinreads
GLP-1 Digest: https://www.glp1digest.com/
By Paul CerroTelehealth Industry Trends and Challenges with Ash SharmaIn this episode of The Investors Corner Podcast by Cedar Grove Capital Management, Chief Investment Officer Paul Cerro welcomes Ash Sharma, writer and founder of the GLP One Digest.
They discuss the evolution and future of telehealth, touching on topics such as consumer health behaviors, limitations and dark sides of telehealth services, and the business model of labs and diagnostics. They delve into the controversial practices within the industry, such as compounded treatments and ethical concerns. The conversation also covers international expansion of telehealth services, particularly in the UK market, and the challenges HIMS is facing with new product offerings.
Finally, they explore the importance of proactive versus reactive healthcare and the impact of tech advancements such as wearables in promoting healthy lifestyles.00:00 Introduction and Guest Introduction03:40 Telehealth Evolution and Market Impact06:49 Limitations and Challenges of Telehealth14:10 The Dark Side of Telehealth23:02 Preventative vs. Reactive Healthcare30:36 HIMSS and Lab Biomarkers Discussion35:18 The Cost of Medical Devices36:03 Compounding Treatments and Business Strategies37:34 Diagnostic Blood Tests and Health Anxiety39:27 The Business of Biomarkers and Medications41:35 Cancer Diagnostics and False Positives45:53 New Product Releases: TRT, HRT, and Peptides54:33 International Expansion and Market Challenges59:46 Telehealth Industry Insights and HIMSS Future01:03:25 Concluding Thoughts and RecommendationsCedar Grove Capital Management Fund: www.cedargrovecapitalmanagement.com
Cedar Grove Capital Management Research: www.cedargroveresearch.comPaul Cerro Twitter: https://x.com/paulcerro
Fund Twitter: https://x.com/cedargrovecm
Ash Twitter: https://x.com/Ashwinreads
GLP-1 Digest: https://www.glp1digest.com/